{"filing":{"accession_number":"0001628280-26-041886","cik":"0001673743","ticker":"HNGE","company_name":"Hinge Health, Inc.","form":"8-K","filing_date":"2026-06-09","report_date":null,"primary_document":"hnge-20260609.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1673743/000162828026041886/hnge-20260609.htm"},"events":[{"id":6052,"run_id":5313,"accession_number":"0001628280-26-041886","anchor_item_number":"7.01","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.85,"summary":"The disclosure announces raising guidance for Q2 2026 and full year 2026, which constitutes material forward-looking financial guidance that would affect a reasonable investor's assessment of the company's expected performance. While the Item 7.01 designation and Regulation FD language indicate this is a non-binding disclosure, the substance is a material earnings/guidance announcement tied to the investor day event.","company_name":"Hinge Health, Inc.","ticker":"HNGE","filing_date":"2026-06-09","form":"8-K","submitted_at":null,"items":[{"id":5501,"accession_number":"0001628280-26-041886","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"The disclosure announces raising guidance for Q2 2026 and full year 2026, which constitutes material forward-looking financial guidance that would affect a reasonable investor's assessment of the company's expected performance. While the Item 7.01 designation and Regulation FD language indicate this is a non-binding disclosure, the substance is a material earnings/guidance announcement tied to the investor day event.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-09T20:09:09.019092+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":5501,"accession_number":"0001628280-26-041886","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"The disclosure announces raising guidance for Q2 2026 and full year 2026, which constitutes material forward-looking financial guidance that would affect a reasonable investor's assessment of the company's expected performance. While the Item 7.01 designation and Regulation FD language indicate this is a non-binding disclosure, the substance is a material earnings/guidance announcement tied to the investor day event.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-09T20:09:09.019092+00:00","company_name":"Hinge Health, Inc.","ticker":"HNGE","filing_date":"2026-06-09"}]}